Efficacy and safety of saxagliptin compared with acarbose in <scp>C</scp> hinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: <scp>R</scp> esults of a <scp>P</scp> hase <scp>IV</scp> open‐label randomized controlled study (the <scp>SMART</scp> study)

Abstract

NCT02243176, clinicaltrials.gov.